Source: The Endocrine Society | Summary: Women of reproductive age who have thyroid cancer should be cautious about receiving radioactive iodine treatment, which affects their remaining egg supply -- their ovarian reserve -- and may affect their fertility, new research from finds.
"Women of reproductive age who have thyroid cancer should be cautious about receiving radioactive iodine treatment, which affects their remaining egg supply -- their ovarian reserve -- and may affect their fertility, new research from Israel finds. The results of this ongoing study will be presented Saturday, April 2, at ENDO 2016, the annual meeting of the Endocrine Society in Boston.
"This is the first study ever to prospectively address the impact of radioactive iodine treatment on ovarian reserve. In our day and age, when growing numbers of women of reproductive age are diagnosed with thyroid cancer and when fertility problems are rampant, these findings should serve as an additional consideration for physicians contemplating radioactive iodine for their patients," said senior author Karen Tordjman, MD, associate professor of medicine at the Sackler Faculty of Medicine of Tel Aviv University.
"Low-risk thyroid cancer patients may not derive any survival advantage from the treatment but may end up paying the cost of decreased fertility..."
Read more here:
No comments:
Post a Comment